Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.36 |
| ▸ | GNPAT | O15228 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
| ▸ | ODC1 | P11926 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1704900 | 1.00 | FOLH1 (0.46) | FOLH1GGT1CPB2GSRRNPEP | |
| Hydrochloric Acid SCHEMBL10783565 | 0.98 | FOLH1 (0.45) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL7204379 | 0.94 | FOLH1 (0.53) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL30612329 | 0.94 | FOLH1 (0.53) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL146727 | 0.82 | GGT1 (0.55) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL6890284 | 0.82 | GGT1 (0.55) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL7198357 | 0.82 | FOLH1 (0.47) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL4951214 | 0.82 | GGT1 (0.65) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL8768872 | 0.82 | FOLH1 (0.47) | FOLH1GGT1CPB2GSRRNPEP | |
| SCHEMBL4951210 | 0.82 | GGT1 (0.65) | FOLH1GGT1CPB2GSRRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117321025-A | (S) -3-amino-4, 4-dihalocyclopent-1-enecarboxylic acid as selective inactivating agent for human ornithine aminotransferase | 西北大学 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023049918-A2 | CELLS EXPRESSING ANTIGEN- & SEQUENCE-SPECIFIC T-CELL RECEPTORS (TCRS) AND METHODS OF MAKING THE SAME USING ENFORCED TCR GENE REARRANGEMENT | Century Therapeutics, Inc. (US) | 2023-03-30 | — | — | WO | disclosed |
| EP-2440195-B1 | USE OF ALKYLGLYCEROLS FOR PREPARING DRUGS | UNIV RENNES (FR) | 2019-11-06 | — | — | EP | disclosed |
| EP-3143015-A1 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | ARIAD Pharmaceuticals, Inc. (US) | 2017-03-22 | — | — | EP | disclosed |
| EP-1373185-B1 | HYDROPHOBIC POLYAMINE ANALOGS AND METHODS FOR THEIR USE | AMINEX THERAPEUTICS INC (US) | 2017-03-01 | — | — | EP | disclosed |
| WO-2015175632-A1 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | ARIAD PHARMACEUTICALS, INC. (US) | 2015-11-19 | — | — | WO | disclosed |
| US-9023417-B2 | Use of a polyamine-poor composition for the production of a medical human food | Univeriste de Rennes 1 (FR) | 2015-05-05 | — | — | US | disclosed |
| US-8778911-B2 | Use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product | UNIVERSITE DE RENNES 1 (FR) | 2014-07-15 | — | — | US | disclosed |
| EP-2640425-A2 | METHODS OF TREATING OBESITY BY INHIBITING NICOTINAMIDE N-METHYL TRANSFERASE (NNMT) | Beth Israel Deaconess Medical Center, Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| WO-2012068463-A2 | METHODS OF TREATING OBESITY BY INHIBITING NICOTINAMIDE N-METHYL TRANSFERASE (NNMT) | BETH ISRAEL DEACONESS MEDICALL CENTER, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2002053519-A2 | HYDROPHOBIC POLYAMINE ANALOGS AND METHODS FOR THEIR USE | MEDIQUEST THERAPEUTICS, INC. (US) | 2002-07-11 | — | — | WO | disclosed |
| EP-0703731-B1 | FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT, AND THERAPEUTICAL USES THEREOF | UNIV RENNES (FR) | 1998-04-08 | — | — | EP | disclosed |
| EP-0703732-B1 | FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT | UNIV RENNES (FR) | 1997-09-17 | — | — | EP | disclosed |
| EP-0703731-A1 | FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT, AND THERAPEUTICAL USES THEREOF | UNIVERSITE DE RENNES I (FR) | 1996-04-03 | — | — | EP | disclosed |
| EP-0703732-A1 | FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT | UNIV RENNES (FR) | 1996-04-03 | — | — | EP | disclosed |
| WO-1995000041-A1 | FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT, AND THERAPEUTICAL USES THEREOF | UNIVERSITE DE RENNES 1 (FR) | 1995-01-05 | — | — | WO | disclosed |
| WO-1995000042-A2 | FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT | UNIVERSITE DE RENNES 1 (FR) | 1995-01-05 | — | — | WO | disclosed |
| WO-1989003224-A1 | PRODUCT CONTAINING AS ACTIVE PRINCIPLES: A) A PEPTIDE HAVING AN ACTIVITY OF THE TYPE OF THAT OF HUMAN GAMMA INTERFERON, B) HYDROXYUREA | ROUSSEL-UCLAF (FR) | 1989-04-20 | — | — | WO | disclosed |
| EP-0288055-A1 | Use of ODC inhibitors, dacarbazine, and interferon, in the treatment of malignant melanoma | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-10-26 | — | — | EP | disclosed |
| US-4760091-A | Applying fungicidally effective amount of an ornithine decarboxylase inhibitor | THE DOW CHEMICAL COMPANY (US) | 1988-07-26 | — | — | US | disclosed |